Technology

Transforming Drug Delivery to the Eye

Short animation that shows how the Vitradel technology works

Drug delivery

Constant daily dose over a 6-12 month period

Functionalised Polymer

Tunable drug release, controlled biodegradation

In situ cross linking

Well-tolerated, safe implant with non-toxic by-products